Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,695 | -3,012 | -1,804 | -6,207 | -4,563 |
| Depreciation Amortization | 165 | 110 | 55 | 220 | 165 |
| Accounts payable and accrued liabilities | 264 | 349 | 221 | 62 | 52 |
| Other Working Capital | 87 | -164 | 99 | 149 | 112 |
| Other Operating Activity | 1,754 | -1 | 84 | 1,559 | 914 |
| Operating Cash Flow | $-4,426 | $-2,718 | $-1,345 | $-4,218 | $-3,321 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -23 | -23 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -35 | -35 |
| Other Investing Activity | -1,000 | 0 | 0 | -35 | -35 |
| Investing Cash Flow | $-1,000 | $N/A | $N/A | $-59 | $-59 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,609 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 2,323 | 0 | 9,328 | 7,140 |
| Financing Cash Flow | $6,609 | $2,323 | $N/A | $9,328 | $7,140 |
| Beginning Cash Position | 14,275 | 14,275 | 14,275 | 9,224 | 9,224 |
| End Cash Position | 15,458 | 13,880 | 12,930 | 14,275 | 12,984 |
| Net Cash Flow | $1,183 | $-395 | $-1,345 | $5,051 | $3,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,426 | -2,718 | -1,345 | -4,218 | -3,321 |
| Capital Expenditure | 0 | N/A | N/A | -23 | -23 |
| Free Cash Flow | -4,426 | -2,718 | -1,345 | -4,241 | -3,345 |